NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.31 -0.13 (-5.53%)
As of: Nov 12, 2026 · 12:41 PM EST

NRX Pharmaceuticals (NRXP) Cost of Revenue (2025 - 2026)

Updated

NRX Pharmaceuticals' Cost of Revenue came in at $675,000 for Q2 2026, up 7.0% from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Cost of Revenue (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, NRX Pharmaceuticals reported Cost of Revenue of $1.81 million; for FY2025, it came in at $505,000.

  • Business Quant data shows NRXP's Cost of Revenue at $631,000 (Q1 2026), $408,000 (Q4 2025) and $97,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.29 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.95 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.57 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.03 Bn
10 NRX Pharmaceuticals 101.85 Mn 53.44 Mn 426,000.00 675,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 675,000.00
Mar 31, 2026 631,000.00
Dec 31, 2025 408,000.00
Sep 30, 2025 97,000.00
API Access

NRX Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=NRXP&period=max&api_key=YOUR_API_KEY